OPION MED
OPION MED is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 0 yrs |
| Locations | 1 |
| Publications | 1 |
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 26-05-2026 |
| Status | Active |
| Postal code | 1030 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21015A0484/00Y003 | Brussels | 229 m² | 1 · 220 m² | 18.7 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
28-05-2026 Incorporation of a new SRL
Technical details
{
"notary": {
"name": "Ma\u00EEtre Sandrine KOEUNE",
"firm_city": null,
"firm_name": "NOTALIBREX, soci\u00E9t\u00E9 notariale",
"office_city": "Mons",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-05-28",
"filing_date": "2026-05-26",
"act_kind_objet": "Onderwerp akte:",
"is_private_deed": false
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2026-05-18",
"unanimous": true
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "YMERAJ Senada",
"niss": null,
"address": "1030 Bruxelles, Avenue Princesse Elisabeth, 76/ET01",
"nationality": null,
"place_of_birth": null
},
"share_class": null,
"partner_role": "null",
"contribution_type": "geld",
"amount_paid_in_eur": 7000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 7000.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet l\u2019exercice en son nom et pour son compte de la m\u00E9decine g\u00E9n\u00E9rale. La soci\u00E9t\u00E9 s\u2019interdit toute exploitation commerciale de la m\u00E9decine, toute forme de collusion directe ou indirecte, de dichotomie ou de surconsommation. La responsabilit\u00E9 professionnelle de chaque m\u00E9decin actionnaire est toujours illimit\u00E9e, elle doit \u00EAtre assur\u00E9e de fa\u00E7on \u00E0 r\u00E9parer le dommage \u00E9ventuellement caus\u00E9. A titre accessoire, la soci\u00E9t\u00E9 a \u00E9galement pour objet la gestion et la valorisation d\u2019un patrimoine immobilier, notamment par l\u2019achat, la vente, la location, la mise en location, la construction, le tout au sens le plus large, pour autant que n\u2019en soit alt\u00E9r\u00E9e sa vocation prioritairement m\u00E9dicale et que ces op\u00E9rations s\u2019inscrivent dans les limites d\u2019une gestion \u00AB en bon p\u00E8re de famille \u00BB n\u2019aient pas un caract\u00E8re r\u00E9p\u00E9titif et commercial. Distribuer \u00E0 ses actionnaires un avantage patrimonial direct ou indirect.",
"is_lucrative": true,
"short_summary": "De onderneming heeft als doel het uitoefenen van de algemene geneeskunde en de beheersing van een onroerend goedpatrimonium in het kader van een goede zorgpraktijk."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": 1,
"n_directors_min": 1,
"representation_clause": "enige bestuurder alleen",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "06-30",
"start_mm_dd": "07-01",
"first_exercise_end_date": "2027-06-30",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "18:00",
"month": 1,
"rule_text": "laatste dag van januari"
},
"founding_event": {
"n_shares_total": 100,
"n_share_classes": 1,
"bank_attestation": {
"date": "2026-05-18",
"bank_name": "KBC",
"amount_eur": 7000.0,
"iban_masked": "BE43 3632 6778 4001"
},
"amount_paid_in_eur": 7000.0,
"incorporation_date": "2026-05-18",
"amount_subscribed_eur": 7000.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": "2026-04-01"
},
"subject_company": {
"kbo": "1038.320.068",
"email": null,
"region": "brussels_hoofdstedelijk_gewest",
"website": null,
"name_full": "OPION MED",
"legal_form": "SRL",
"name_abbreviated": null,
"zetel_address_raw": "Avenue Princesse Elisabeth 76, 1030 Schaerbeek",
"equity_account_type": "available"
},
"initial_directors": [
{
"kind": "natural_person",
"person": {
"name": "YMERAJ Senada",
"address": "1030 Bruxelles, Avenue Princesse Elisabeth, 76/ET01"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"volmacht"
],
"post_incorporation_mandates": [
{
"kind": "mandataire_ad_hoc",
"holder_org_kbo": "0416.176.817",
"holder_org_name": "SRL DG CONSULT",
"with_substitution": false,
"holder_person_name": null
}
]
}| Legal nameFR | OPION MED |